Literature DB >> 19554528

[Rationale, pros and cons of GFR estimation: the Cockcroft-Gault and MDRD equations].

M Cirillo1.   

Abstract

Current guidelines suggest to evaluate kidney function by estimates of the glomerular filtration rate (GFR) calculated using the Cockcroft-Gault equation or the simplified equation of the Modification of Diet in Renal Disease (MDRD) study. Cockcroft and Gault developed a method to predict an individual's creatinine clearance without urinary data but on the basis of average creatinine clearance values corrected for age and body weight. The equation needs information about gender, age, weight, and serum creatinine. The precision of the equation is biased by overweight because the equation is based on the assumption that creatinine clearance linearly reflects body weight. The MDRD equation derives from a multiple regression used to analyze the relation of GFR measurements by a radioisotope technique over serum creatinine after data linearization by logarithm transformation and with control for gender, age, ethnicity and other variables. The equation has not been validated for GFR >60 mL/min x 1.73 m2 because the study did not include healthy persons. The two equations often give conflicting estimates of GFR. Nephrologists have to understand the rationale of the two equations for the correct interpretation of these discrepancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554528

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  6 in total

1.  Association between renal function and chemotherapy-related toxicity in older adults with cancer.

Authors:  Lindsay L Peterson; Arti Hurria; Tao Feng; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Ilya Glezerman; Vani Katheria; Laura Zavala; David D Smith; Can-Lan Sun; William P Tew
Journal:  J Geriatr Oncol       Date:  2016-11-14       Impact factor: 3.599

2.  Chronic kidney disease: Prognostic marker of nonfatal pulmonary thromboembolism.

Authors:  Anca Ouatu; Daniela Maria Tãnase; Mariana Floria; Simona Daniela Ionescu; Valentin Ambãruş; Cãtãlina Arsenescu-Georgescu
Journal:  Anatol J Cardiol       Date:  2014-12-31       Impact factor: 1.596

3.  Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.

Authors:  In Gyu Hwang; Minsuk Kwon; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; Soojung Hong; Tae-Yong Kim; Sun Young Kim; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Kyung Hee Lee; Sung Hwa Bae; Dong-Hoe Koo; Jee Hyun Kim; In Sook Woo
Journal:  Cancers (Basel)       Date:  2021-01-18       Impact factor: 6.639

4.  Drugs Dosing in Geriatric Patients Depending on Kidney Function Estimated by MDRD and Cockroft-Gault Formulas.

Authors:  Małgorzata Szymala-Pędzik; Joanna Żórawska; Jacek Ciach
Journal:  Clin Interv Aging       Date:  2021-12-10       Impact factor: 4.458

5.  SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM).

Authors:  Antonio Orlacchio; Carlo Guastoni; Giordano Domenico Beretta; Laura Cosmai; Michele Galluzzo; Stefania Gori; Emanuele Grassedonio; Lorena Incorvaia; Carmelita Marcantoni; Giuseppe Stefano Netti; Matteo Passamonti; Camillo Porta; Giuseppe Procopio; Mimma Rizzo; Silvia Roma; Laura Romanini; Fulvio Stacul; Alice Casinelli
Journal:  Radiol Med       Date:  2022-03-18       Impact factor: 6.313

6.  Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges.

Authors:  Ahmed E Abou Warda; Rania M Sarhan; Hussein Saeed Al-Fishawy; Ayman N Moharram; Heba F Salem
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.